Primary biliary cirrhosis clinical research single-topic conference.
Lindor
K D
KD
Mayo Foundation, Rochester, MN 55905, USA.
Hoofnagle
J
J
Maddrey
W C
WC
Mackay
I E
IE
Dickson
E R
ER
D042942:3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide); D001324:Autoantigens / Q000276:immunology; D002756:Cholagogues and Choleretics / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007658:Ketone Oxidoreductases / Q000276:immunology; D008105:Liver Cirrhosis, Biliary / Q000188:drug therapy / Q000201:enzymology / Q000276:immunology; D008727:Methotrexate / Q000627:therapeutic use; D009097:Multienzyme Complexes / Q000276:immunology; D012106:Research; D014580:Ursodeoxycholic Acid / Q000627:therapeutic use
D001324:Autoantigens; D002756:Cholagogues and Choleretics; D007166:Immunosuppressive Agents; D009097:Multienzyme Complexes; D014580:Ursodeoxycholic Acid; D007658:Ketone Oxidoreductases; D042942:3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide); D008727:Methotrexate